Skip to main content

Chin Augmentation

0
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Galderma
GaldermaTX - Dallas
2 programs
Restylane Lyft with LidocaineN/A1 trial
Restylane ShaypeN/A1 trial
Active Trials
NCT05777759Completed174Est. Jul 2024
NCT06428214Completed45Est. Sep 2024

Trial Timeline

Clinical trial activity over time

2023
2024
2025
2026
GaldermaRestylane Shaype
GaldermaRestylane Lyft with Lidocaine

Clinical Trials (2)

Total enrollment: 219 patients across 2 trials

NCT06428214GaldermaRestylane Shaype

A Restylane Treatment Algorithm Approach for Participants With Appearance of Insufficient Bone Structure in the Lower Face Alone or in Combination With Facial Soft Tissue Deficiencies

Start: May 2024Est. completion: Sep 202445 patients
N/ACompleted
NCT05777759GaldermaRestylane Lyft with Lidocaine

Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile

Start: Mar 2023Est. completion: Jul 2024174 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.